Modulatory Effect of Dopamine on Doxorubicin-induced Myelosuppression
Modulatory Effect of Dopamine on Doxorubicin-induced Myelosuppression
About this item
Full title
Author / Creator
Ray, M. R. , Lakshmi, C. , Deb, C. , Ray, C. and Lahiri, T.
Publisher
London: Springer Nature B.V
Journal title
Language
English
Formats
Publication information
Publisher
London: Springer Nature B.V
Subjects
More information
Scope and Contents
Contents
Bone marrow suppression is a dose-limiting toxicity of anticancer drugs. We have investigated in this study whether dopamine (DA), a catecholamine neurotransmitter, could alleviate the haematotoxicity of doxorubicin (DXN), an established anticancer drug having profound myelotoxicity. DA was injected intraperitoneally at a dose of 50 mg/kg/day for f...
Alternative Titles
Full title
Modulatory Effect of Dopamine on Doxorubicin-induced Myelosuppression
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1112408608
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1112408608
Other Identifiers
ISSN
0938-7714,1618-5641
E-ISSN
1433-2973,1618-565X
DOI
10.1007/s005800170008
